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Laboratory Medicine, Clinical Microbiology, University Hospital, Örebro, SwedenAbstractSore throat is common in primary healthcare. Aetiological studies have focused on the presence of a limited number of pathogens. The aim of
the present study was to investigate the presence of a wide range of bacteria and viruses, including Fusobacterium necrophorum, in patients with
pharyngotonsillitis and in asymptomatic controls. A prospective case control study was performed in primary healthcare in Kronoberg
County, Sweden. Patients (n = 220) aged 15 to 45 years with a suspected acute pharyngotonsillitis, and controls (n = 128), were included.
Nasopharyngeal and throat swabs were analysed for β-hemolytic streptococci, F. necrophorum, Mycoplasma pneumoniae, and Chlamydophila
pneumoniae, and 13 respiratory viruses. Serum samples were analysed for antibodies to Epstein-Barr virus. The patient history and
symptoms, including Centor score, were analysed in relation to pathogens. In 155/220 (70.5%) of the patients, as compared to 26/128
(20.3%) of the controls (p <0.001), at least one microorganism was found. Group A streptococci, F. necrophorum, and inﬂuenza B virus
were the three most common ﬁndings, and all signiﬁcantly more common in patients than in controls (p <0.001, p 0.001, and p 0.002,
respectively). Patients with F. necrophorum only (n = 14) displayed a lower Centor score than patients with Group A streptococcus only
(n = 46), but a higher score than patients with inﬂuenza B, other viruses, or no potential pathogen (Kruskal-Wallis p <0.001). A pathogen
was detected in 70% of the patients, displaying a wide range of pathogens contributing to the aetiology of pharyngotonsillitis. This study
supports F. necrophorum as one of the pathogens to be considered in the aetiology of pharyngotonsillitis.
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E-mail: katarina.hedin@ltkronoberg.seIntroductionA sore throat is a common complaint in primary healthcare
(PHC) [1]. The condition can be caused by a wide variety of
infectious agents [2], where the most common is Streptococcus
pyogenes (Group A streptococci, GAS) [3–5]. Also, large col-
ony variants of Streptococcus group C and G [6], Mycoplasmalinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infepneumoniae [3], Arcanobacterium haemolyticum [7], and several
viruses [3,5,8] have been associated with a sore throat.
The aetiology has mainly been studied in children [9,10], and
most studies have been performed with a focus on the pres-
ence of a limited number of pathogens [3,5], and studies
covering both viral and bacterial aetiology are lacking [5]. The
criteria presented by Centor et al. 30 years ago were developed
to predict the presence of GAS as the cause of the patients’
symptoms, and thus predict the patients who were considered
in need of antibiotic therapy [11].
In recent years, the anaerobic Gram-negative bacterium
Fusobacterium necrophorum has been suggested as an important
cause of acute pharyngotonsillitis in adolescents and youngClin Microbiol Infect 2015; 21: 263.e1–263.e7
ctious Diseases .Published by Elsevier Ltd .
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an increase of severe infections caused by F. necrophorum
(Lemièrre syndrome) [15,16]. This conclusion is not, however,
generally accepted [17], as the increase may be due to publi-
cation bias [18,19]. The studies focusing on F. necrophorum as a
throat pathogen have, so far, been based on routine clinical
microbiology data and have focused on the presence of this
bacterium only [12,14,15].
The aim of the present study was to investigate the presence
of F. necrophorum together with β-hemolytic streptococci, My-
coplasma pneumoniae, Chlamydophila pneumoniae, and 14 res-
piratory viruses in adults attending PHC with the symptoms of
pharyngotonsillitis, compared to asymptomatic controls. The
second aim was to investigate the association of these patho-
gens to the patient’s history and symptoms and signs, and in
relation to the Centor score in particular.Material and methodsSetting
A prospective case control study was conducted in ﬁve primary
healthcare centres (PHCC) in Kronoberg County, Sweden.
Data were collected between January 15 and April 30, 2011 and
from October 1, 2011 to April 15, 2012.
Study population
Patients. Patients aged 15 to 45 years with a suspected acute
pharyngotonsillitis who contacted the PHCC and were
considered in need of a consultation by the physician according
to the national Swedish guidelines [20], were recruited. Ac-
cording to standard procedures, all patients contacted the
PHCC via telephone, and a nurse primarily assessed if the pa-
tient’s symptoms called for a visit to the physician. Informed
consent was obtained and the physician made the study
assessment during the consultation. This included the Centor
criteria, i.e. absence of cough, fever >38.5°C, tender lymph-
adenitis, and tonsillar coating, as well as potential confounders
such as smoking habits, recent antibiotic treatment, history of
sore throat, and the duration of symptoms prior to the
consultation. Since the study did not interfere with the clinical
management, the risk for bias was minimal.
Controls. Patients 15 to 45 years old visiting the PHCC for any
medical reason other than an infection were recruited as a
control group during the same time periods. Informed consent
was obtained before sampling was performed. A questionnaire
including questions about potential confounders such as
recurrent sore throat, smoking habits, and antibiotic treatment
in the last month was completed.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
Open access under CC BY-NC-ND license.Sampling
All sampling was performed by staff at the PHCCs. A swab for
the culture of β-hemolytic streptococci and F. necrophorum was
obtained by rolling the swab on the tonsils at both sides and
placing it in Amies medium with charcoal (Copan, Brescia,
Italy). Two samples for the analyses of respiratory viruses My-
coplasma pneumoniae and Chlamydophila pneumoniae were ob-
tained using ﬂocked swabs transported in 3 mL of Universal
Transport Medium (UTM; Copan), one from the pharynx and
one from the nasopharynx. In the patient group, a capillary
blood sample was obtained for the analysis of Epstein-Barr virus
(EBV)-speciﬁc antibodies. According to the procedures used in
the county at the time of the study, the result of the culture for
β-hemolytic streptococci was reported to the physician.
Microbiological procedures
All samples were stored in a refrigerator and transported to the
Department of Clinical Microbiology, Central Hospital, Växjö.
Throat swabs were cultured for the recovery of β-hemolytic
streptococci (Lanceﬁeld group A, C, and G), using a double-
layered agar (Columbia agar (Oxoid, Basingstokes, UK)
covered with sheep blood agar, blood agar base (Merck,
Darmstadt, Germany) with 5% sheep blood (SVA, Uppsala,
Sweden), and 5 mg/mL methyl violet (Merck, Darmstadt, Ger-
many) with a bacitracin disc (0.2 IU)). For F. necrophorum, a
selective anaerobic plate (fastidious anaerobe agar (Lab M) with
5% horse blood (SVA) supplemented with vancomycin 2.5 mg/L
(ICN Biomedicals, Irvine, CA, USA) and nalidixic acid 5.0 mg/L
(MP Biomedicals, Santa Ana, CA, USA)), and with a kanamycin
tablet 500 μg (Rosco, Taastrup, Denmark) was used [21]. The
agar plates were incubated under anaerobic conditions in
35–37°C for 1 and 4 days, respectively. For species identiﬁ-
cation, Streptex (Remel Europe Ltd., Dartford, England) and
MALDI-TOF (Microﬂex mass-spectrometer and Biotyper 3.1
software, Bruker Daltonics, Bremen, Germany) were used.
All samples transported in UTM were stored in −80°C until
shipped on dry ice to the Department of Clinical Microbiology,
Sahlgrenska University Hospital, Gothenburg, Sweden for
further analyses. All samples were analysed using multiplexed
PCRs for 13 respiratory viruses and the two intracellular bac-
teria M. pneumoniae and C. pneumoniae as previously described
[22]. Any detected DNA or RNA was considered a positive
result.
The blood samples were centrifuged at 3000 rpm for 10
minutes, and the sera were stored in −20°C until analyses were
performed. All samples were screened for the presence of
Epstein-Barr virus nucleic antigen – antibodies (EBNA)
(Novagnost EBV-EBNA IgG; Siemens, Tarrytown, NY, USA) on
a BEP2000 (Siemens). Samples negative for EBNA were ana-
lysed with EBV IgM (Enzygnost Anti-EBV/IgM II; Siemens) andious Diseases. Published by Elsevier Ltd. CMI, 21, 263.e1–263.e7
TABLE 1. Characteristics of the study population
Percent
χ2
p
Patients
(n[ 220)
Control group
(n[ 128)
Female 64.1 75.8 0.02
Smoker 14.0 8.1 0.10
A history of often having a sore throat 33.3 7.3 <0.001
Previous tonsillectomy 13.2 12.1 0.76
Antibiotic treatment in the last month 7.9 5.6 0.44
CMI Hedin et al. Aetiology of pharyngotonsillitis in adults 263.e3EBV-Viral Capsid Antigen IgG (VCA IgG, (Enzygnost Anti-EBV/
IgG; Siemens)). Patients with positive EBV IgM with or without
VCA IgG were considered to have a primary EBV infection.
Routine microbiology data
Sampling strategies and detection techniques for the routine
diagnostics of β-hemolytic streptococci (culture), inﬂuenza A
and B (PCR), and M. pneumoniae (PCR) were not changed
during the study period. All samples analysed for these patho-
gens were retrieved from the LIS system (ADBakt, Autonik AB,
Sköldinge, Sweden) at the Department of Clinical Microbiology,
Växjö from August 2010 to July 2012, and the proportion of
positive samples were analysed on a monthly basis and
compared to the study data.
Statistical analyses
To be able to detect a 10% difference in the presence of
F. necrophorum between the patients and the controls, 180
patients had to be included given a power of 0.80 and an α value
of 0.05. The statistical analyses were performed using the SPSS
20.0 software (IBM, Armonk, NY, USA). For descriptive sta-
tistics, median values and proportions were used. Comparisons
between proportions of categorical variables in two indepen-
dent groups were performed using the χ2 test or Fisher’s exact
test, when expected frequencies were small. Multiple logistic
regressions were used to model the relationship between the
outcome variable and several independent variables. The
Kruskal-Wallis test was used when comparing medians in more
than two groups. Missing data were <2% for all variables among
the patients except for tonsillar coating, where 6% (14/220) was
missing. Among the controls, background data were missing for
3% (4/120) of the individuals.
Ethical considerations
The study was approved by the regional ethics board in Link-
öping, Sweden, Drn: 2010/267-31. All patients and controls
received written information about the study before seeing the
physician. The patients had the opportunity to ask questions
about the study before informed consent was obtained. The
sampling methods used in this study were well established and
familiar to the personnel performing the sampling, and thus
were regarded as safe for the included patients and controls.ResultsCharacteristics of the patients and controls
In total, 220 patients and 128 controls were recruited. The
median age was 33 years (range 15–48 years) in the patient
group and 31 years (range 16–46 years) in the control group.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and In
Open access under CC BY-NC-ND license.Characteristics of the study population are presented in
Table 1. All patients were evaluated according to the symptoms
and signs building up the Centor score. The median Centor
score was 2 (14.1% presented with Centor score 4, 24.5 % with
a score of 3, 31.4% score 2, 22.7% score 1, and 7.3 % with
score 0).
Aetiology
The detection of bacteria and viruses in patients and controls. In
155/220 (70.5%) of the patients, as compared to 26/128 (20.3%)
of the controls, (p <0.001), at least one bacterium or virus was
found. The corresponding ﬁgures for viruses, independent of
the presence of bacteria, were 70 (31.8%) and 11 (8.6%) (p
<0.001), respectively, while at least one bacterium, with or
without the presence of viruses, was found in 103 (46.8%)
patients and in 17 (13.3%) controls (p <0.001). In 58 (26.4%)
patients, more than one microorganism was found. Two bac-
teria or viruses were found in 20.9%, three in 4.1% and four in
1.4% of the patients. The most common combination was GAS
and F. necrophorum (n = 11). Six of the controls were positive
for more than one microorganism.
The distribution of the bacteria and viruses found is pre-
sented (see Results section). GAS (p <0.001), F. necrophorum (p
0.001), and inﬂuenza B (p <0.002) were signiﬁcantly more
commonly found among the patients than among controls, and
represented the three most common ﬁndings in the patient
group.
Bacteria and viruses found in patients with the suspicion of phar-
yngotonsillitis. Except for C. pneumoniae, all tested bacteria and
viruses were found in at least one patient. Of the 103 (46.8%)
patients positive for bacteria, 15 (14.6%) were infected with
more than one bacterial species, and 16 (15.5%) had a
concomitant ﬁnding of at least one virus. GAS was the most
common ﬁnding (n = 66), followed by F. necrophorum (n = 33),
inﬂuenza B virus (n = 16), and rhinoviruses (n = 14) (Table 2).
EBNA IgG was found in 197/220 (89.6%) of the patients, indi-
cating previous primary infection. Of the EBNA-negative pa-
tients, ﬁve were deemed to have a present EBV infection. The
full pattern of coexistence of the analysed bacteria and viruses is
shown in Supplementary Table 1.fectious Diseases. Published by Elsevier Ltd. CMI, 21, 263.e1–263.e7
TABLE 2. Bacteria and viruses detected through culture,
multiplexed PCRs, or serology in patients with a sore throat
and in controls
Percent (number of patients)
Patients Controls
Fisher or
χ2 testa
(n[ 220) (n[ 128) p
GAS 30 (66) 2.3 (3) <0.001a
GCS 3.6 (8) 0.8 (1) 0.16
GGS 3.2 (7) 7.0 (9) 0.10a
Fusobacterium necrophorum 15.0 (33) 3.1 (4) 0.001a
Chlamydophila pneumoniae 0 0 —
Mycoplasma pneumoniae 1.8 (4) 0.8 (1) 0.66
Adenovirus 4.1 (9) 1.6 (2) 0.34
Bocavirus 0.5 (1) 0.8 (1) 1.0
Coronavirus NL63 1.8 (4) 0 0.30
Coronavirus OC43 1.8 (4) 0 0.30
Coronavirus HKU1 0.9 (2) 1.6 (2) 0.63
Coronavirus 229E 1.4 (3) 0.8 (1) 1.0
EBV 5 (2.3) NA —
Enterovirus 0.5 (1) 0.8 (1) 1.0
Inﬂuenza A virus 1.8 (4) 0 0.30
Inﬂuenza B virus 7.3 (16) 0 0.002a
Metapneumovirus 1.8 (4) 0 0.30
Parainﬂuenzavirus 0.5 (1) 0 1.0
Rhinovirus 6.4 (14) 2.3 (3) 0.09a
RSV 1.8 (4) 1.6 (2) 1.0
GAS, Group A streptococci; GCS, Group C streptococci; GGS, Group G
streptococci; EBV, Epstein-Barr virus; RSV, respiratory syncytial virus.
Statistical analyses were calculated using χ2 test or Fisher’s exact test.
aχ2 test was used.
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viruses were found either in the throat sample or in the
nasopharyngeal sample (Supplementary Table 2). There was no
signiﬁcant difference in the cycle threshold values (± 1 cycle
threshold) between the different sampling sites, or between
patients with only a virus found or in combination with bacteria,
thus indicating similar amounts of viruses in the samples.
Temporal variations
For several pathogens, the detection rate in the patient group
was unevenly distributed during the study. Adenoviruses (ﬁrst
inclusion period), rhinoviruses (second period), and inﬂuenza B
(ﬁrst period) were found during separate time frames of the
study, while GAS and F. necrophorum were isolated throughout
the inclusion periods. For inﬂuenza B and GAS, the relative
prevalence in the study population at a given time was in
relation to the detection rate in clinical samples (data not
shown).
Microorganisms in relation to symptoms, signs, and
Centor score
The association of bacteria and viruses signiﬁcantly associated
with disease (i.e. only bacteria, only viruses, GAS,
F. necrophorum, and inﬂuenza B virus) to background charac-
teristics, the speciﬁc symptoms and signs and Centor score are
presented in Tables 3 and 4. Patients with only one or severalClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
Open access under CC BY-NC-ND license.bacteria found had a higher median Centor score (56.4% with
Centor score 3, median 3) than patients with viruses only
(25.0% with Centor score3, median 2) (Mann-Whitney U test
p <0.0001). In patients with no bacteria or viruses detected,
24.6% had a Centor score 3 with a median score value of 2.
Patients with F. necrophorum only (n = 14) displayed a lower
Centor score than GAS only (n = 46), but higher than patients
with inﬂuenza B, other viruses, or no potential pathogen found
(Kruskal-Wallis p <0.001). The multiple regression analysis
revealed “being a smoker” and the presence of tonsillar coat-
ings to be of importance for the likelihood of ﬁnding
F. necrophorum (Table 5).DiscussionThis prospective case control study, analysing 20 potential
causative agents of sore throat (6 bacteria and 14 viruses),
could detect at least one of these in 70.5% of patients 15–45
years of age attending PHC with the suspicion of phar-
yngotonsillitis, compared to 20.3% in asymptomatic controls of
the same age. GAS, F. necrophorum, and inﬂuenza B were
signiﬁcantly more common in the patients, and the highest level
of Centor score was found in patients with GAS. Several vi-
ruses (inﬂuenza B, adeno- and rhinovirus) and GAS showed a
marked seasonal variation and thus contributed differently to
the aetiology of pharyngotonsillitis at a given time point.
As far as we know, this is the ﬁrst prospective study with a
broad diagnostic approach, including both bacteria and viruses
that relate to the reported signs and symptoms in patients aged
15–45 years with the suspicion of pharyngotonsillitis. The high
quality of clinical data allowed us to perform analyses on the
relationship between speciﬁc pathogens and patient history,
symptoms, and signs. The summer was considered a low season
of pharyngotonsillitis and therefore not included, the overall
Centor score was relatively low, and the clinical assessment of
the patients was not guided, all of which can be considered
limitations of the study. This, however, reﬂects the patient
group and practice in Swedish PHCs and is therefore consid-
ered relevant. The study was powered to be able to detect a
signiﬁcant difference in the presence of F. necrophorum in
pharyngotonsillitis patients, compared to a control group. Since
the power was not calculated on the associations between
bacteria and viruses and signs or symptoms, we may have
missed some associations. This should encourage further
studies.
We could not identify a potential pathogen in 30% of the
patients. This could be due to sampling, or the detection
methods used [2,3,7]. However, the methods for sampling and
analyses of the samples used here are the same that may beious Diseases. Published by Elsevier Ltd. CMI, 21, 263.e1–263.e7
TABLE 3. Aetiologic agents in relation to the background characteristics of the patients
Patients
n
Background data of the patients
(percent)
Woman Smoker
Often has
a sore throat
Prolonged
sore throat
Previous
tonsillectomy
Treated with
antibiotics the
last 3 months
No pathogen 65 63 16 29 44 12 6
Only viruses 52 65 14 48 29 16 12
Only bacteria 85 68 13 28 26 13 9
GAS (only) 46 70 4 22 30 17 7
Fusobacterium necrophorum (only) 14 74 46 43 36 7 23
Inﬂuenza B (only) 13 69 0 50 15 17 8
GAS, Group A streptococci.
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causes of sore throat have also been reported by other au-
thors [23], but were not included in this study. Interestingly, the
median Centor score in the group of patients with no bacte-
rium or virus found (Centor score 2) were similar to the group
with viruses found, indicating that there may be more infections
due to viruses rather than bacteria being undetected in this
group.
As expected, GAS was the most common pathogen [24].
The Centor score for these patients was higher than for pa-
tients with non-GAS infections, supporting the continuous use
of this score to predict the presence of GAS [5]. There was a
large diversity of the viruses contributing to the aetiology, and
the temporal variation resulted in inﬂuenza B (only period 1)
being the most common viral cause of pharyngotonsillitis in this
age group. Respiratory viruses were also detected in the con-
trol group. This might be seen as over-reporting of the pres-
ence of these viruses due to the high sensitivity of PCR.
However, we would argue, rather, that it reﬂects asymptomatic
infections or prolonged shedding of viruses. Despite the unbi-
ased inclusion, as many as 15% of the patients were culture-
positive for F. necrophorum, while only 3% of the healthy con-
trols were positive for this bacterium. Previously, Aliyu et al.
described patients, aged 5 months to 79 years, with a sore
throat where a routine culture was obtained, and foundTABLE 4. The potential pathogens signiﬁcantly associated with
necrophorum and inﬂuenza B virus) in relation to Centor score, sym
Patients
n
Symptoms and signs in the pa
(%)
No cough Fever L
No pathogen 65 59 43 5
Only viruses 52 33 64 6
Only bacteria 85 79 67 6
GAS (only) 46 87 76 7
Fusobacterium necrophorum (only) 14 64 50 5
Inﬂuenza B (only) 13 8 92 6
GAS, Group A streptococci.
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ﬁnd any F. necrophorum among 100 healthy controls [12].
Amess reported 4.9% of routine throat cultures in the age
group <1–88 years to be positive for F. necrophorum, with the
highest prevalence in patients ages 11–25 years (9.8%) [14]. In
patients 18–32 years of age with “non-streptococcal tonsillitis,”
Jensen et al. identiﬁed F. necrophorum with PCR in almost half of
the samples, and in lower amounts among 21% of the controls
[13]. The use of samples from routine microbiology and “non-
streptococcal” samples will tend, contrary to the prospective
open inclusion used in the present study, to over-report the
pathogen studied. Fusobacterium necrophorum was the only
microorganism found in 14 patients. These patients were not
necessarily less ill than the patients with GAS only, but received
a lower Centor score due to a higher presence of cough.
Although the power of the study was not calculated to rule out
associations between signs and symptoms, this study could not
ﬁnd any association between age [14], recent primary EBV
infection [25], or recurrent sore throat [26] and the detection
of F. necrophorum, as suggested by others. However, smoking
and coating of the tonsils increased the likelihood of detecting
F. necrophorum. Importantly, some of the controls were positive
for F. necrophorum, and the presence of this bacterium is thus
not strictly associated with symptoms. Among nearly two-
thirds of patients with a presence of F. necrophorum, anotherdisease (i.e. only bacteria, only viruses, GAS, Fusobacterium
ptoms and signs
tients Centor score
(%)
ymphadenitis
Tonsillar
coating 0 1 2 3 4
2 28 11 37 28 14 11
2 30 10 27 38 19 6
9 57 4 9 31 33 24
3 60 2 9 22 37 30
7 74 0 7 57 21 14
9 33 8 15 54 23 0
fectious Diseases. Published by Elsevier Ltd. CMI, 21, 263.e1–263.e7
TABLE 5. Presence of any Fusobacterium necrophorum among
patients with pharyngotonsillitis in primary healthcare
Presence of
Presence of any Fusobacterium necrophorum
in the samples
Crude model Adjusted models
OR (95% CI)
Model 1a
aOR (95%CI)
Model 2b
aOR (95%CI)
No cough 1.22 (0.56–2.63)
Lymphadenitis 1.26 (0.57–2.77)
Fever 0.97 (0.45–2.08)
Tonsillar coating 2.87 (1.31–6.24)c 2.66 (1.21–5.85)c 2.75 (1.19–6.33)c
Runny nose 0.16 (0.65–3.06)
Younger than
26 years
0.22 (0.33–1.55)
Smoker 1.37 (0.64–2.93) 3.66 (1.41–9.49)c
Often has a
sore throat
0.38 (0.09–1.68)
Tonsillectomised 0.38 (0.09–1.68)
Crude (univariate) odds ratio (OR) and adjusted ORs (aOR) from the logistic
regressions are presented with 95% conﬁdence intervals (95% CI). aORs were
calculated using multiple logistic regressions with backward elimination of all
variables. The variables in the last step are shown in the adjusted models.
aModel 1 Adjusting for no cough, lymphadenitis, fever, tonsillar coating.
bModel 2 Adjusting for the variable in model 1 and runny nose, younger than 26
years, smoker, often has a sore throat.
cSigniﬁcant ﬁgures.
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and possibly also the pathogenic potential of F. necrophorum,
may thus be facilitated by an underlying inﬂammation.
In conclusion, this study showed that GAS and several res-
piratory viruses, together with F. necrophorum, are of impor-
tance in the aetiology of pharyngotonsillitis. The exact
distribution of each speciﬁc pathogen will, at a given time, be
subjected to local and temporal variations. Both Centor and
Bank et al. have suggested that a broad antibiotic treatment of
tonsillitis could prevent the few cases of severe infection (i.e.
Lemièrre syndrome) [27,28]. We consider this suggestion
premature, as the ﬁnding of F. necrophorum in a predisposing
tonsillitis has not been shown to be of importance for the
development of Lemièrre syndrome, and as the best treatment
option of F. necrophorum has not yet been established. More
studies are warranted to further deﬁne the importance of
F. necrophorum in tonsillitis, establish a standard for how to
handle the ﬁnding of F. necrophorum in pharyngotonsillitis, and
determine whether antibiotic treatment is needed. We urge
diagnostic laboratories to consider the methods needed to ﬁnd
this bacterium in throat swabs (i.e. PCR-based methodology or
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